Daiwa Securities Group Inc. Karyopharm Therapeutics Inc. Transaction History

Daiwa Securities Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$14.15 - $17.19 $3,947 - $4,796	-279 Reduced 66.91%	138 $2,000
Q3 2020 Nov 02, 2020	BUY	$14.14 - $19.71 $890 - $1,241	63 Added 17.8%	417 $6,000
Q4 2019 Jan 31, 2020	SELL	$9.23 - $19.67 $267 - $570	-29 Reduced 7.57%	354 $7,000
Q2 2019 Jul 24, 2019	BUY	$4.32 - $6.43 $527 - $784	122 Added 46.74%	383 $2,000
Q1 2018 May 02, 2018	BUY	$9.92 - $17.25 $2,589 - $4,502	261 New	261 $4,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $54.3M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.